The diminishing returns of atovaquone-proguanil for elimination of Plasmodium falciparum malaria: modelling mass drug administration and treatment
BACKGROUND: Artemisinin resistance is a major threat to current efforts to eliminate Plasmodium falciparum malaria which rely heavily on the continuing efficacy of artemisinin combination therapy (ACT). It has been suggested that ACT should not be used in mass drug administration (MDA) in areas wher...
Main Authors: | Maude, R, Nguon, C, Dondorp, A, White, L, White, N |
---|---|
Format: | Journal article |
Language: | English |
Published: |
BioMed Central
2014
|
Similar Items
-
The pharmacokinetics of atovaquone and proguanil in pregnant women with acute falciparum malaria.
by: Mcgready, R, et al.
Published: (2003) -
Atovaquone/proguanil: a review of its use for the prophylaxis of Plasmodium falciparum malaria.
by: McKeage, K, et al.
Published: (2003) -
Evidence of Plasmodium falciparum malaria resistant to atovaquone and proguanil hydrochloride: case reports.
by: Färnert, A, et al.
Published: (2003) -
Treatment of uncomplicated multidrug-resistant falciparum malaria with artesunate-atovaquone-proguanil.
by: van Vugt, M, et al.
Published: (2002) -
Artesunate-atovaquone-proguanil rescue treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy: a preliminary report.
by: Mcgready, R, et al.
Published: (2003)